Skip to main content
Fig. 2 | Biomarker Research

Fig. 2

From: Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects

Fig. 2

Graphical landscape of current clinical trials using cfDNA methylation in cancer and goals of clinical intervention in cfDNA methylation-based pancreatic cancer trials. A Data refer to a total of 67 studies for different cancer types within 47 clinical trials. B Data refer to a total of 13 studies with different endpoints within 9 pancreatic cancer clinical trials. Information obtained from https://clinicaltrials.gov/ in June 2023, using the following search terms: [condition or disease: “cancer”]; [other terms: “cfDNA methylation”]; [study status: “recruiting and completed”]

Back to article page